4.4 Article

Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: A meta-analysis

Journal

PANCREATOLOGY
Volume 13, Issue 1, Pages 48-57

Publisher

ELSEVIER
DOI: 10.1016/j.pan.2012.11.313

Keywords

Endoscopic ultrasonography; Pancreatic tumours; CEA; Diagnostic and therapeutic endoscopy

Ask authors/readers for more resources

Background and objectives: Mucinous cystic neoplasms and intraductal papillary mucinous tumours have greater malignant potential than serous cystic neoplasms. EUS alone is inadequate for characterising these lesions but the addition of FNA may significantly improve diagnostic accuracy. The performance of EUS-FNA is highly variable in published studies. Aim: To determine the diagnostic accuracy of EUS-FNA to differentiate mucinous versus non-mucinous cystic lesions with cyst fluid analysis for cytology and carcinoembryonic antigen (CEA) by performing a meta-analysis of published studies. Methods: Relevant studies were identified via structured database search and included if they used a reference standard of definitive surgical histology or clinical follow-up of at least 6 months. Data from selected studies were pooled to give summary sensitivity, specificity, positive and negative likelihood ratios, diagnostic odds ratio and Receiver Operating Characteristic (ROC) curve. Pre-defined subgroup analysis was performed. Results: Eighteen studies (published 2002-2011) were included, with a total of 1438 patients. For cytology, pooled sensitivity was 54(95%Cl 49-59)% and specificity 93(90-95)%. The diagnostic odds ratio (DOR) was 133 (4.37-49.43), with I-2 of 77.1%. For CEA sensitivity was 63(59-67)% and specificity 88(83 91)%. The DOR was 10.76(6.29-18.41) with an I-2 of 25.4%. The diagnostic accuracy of EUS-FNA was enhanced in prospective studies and studies of <36 months duration. No impact of publication bias on our results was demonstrated. Conclusions: Fine-needle aspiration has moderate sensitivity but high specificity for mucinous lesions. EUS-FNA, when used in conjunction with cross sectional imaging, is a useful diagnostic tool for the correct identification of mucinous cysts. Copyright (C) 2012, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Potential risks associated with the use of ionizing radiation for imaging and treatment of colorectal cancer in Lynch syndrome patients

Mingzhu Sun, Jayne Moquet, Michele Ellender, Simon Bouffler, Christophe Badie, Rachel Baldwin-Cleland, Kevin Monahan, Andrew Latchford, David Lloyd, Susan Clark, Nicola A. Anyamene, Elizabeth Ainsbury, David Burling

Summary: This review investigates the potential risks of low-dose ionizing radiation to Lynch syndrome patients and explores the impact of CT imaging and radiotherapy. Limited experimental studies suggest that Lynch syndrome cells may be relatively resistant to radiation, but there is a lack of human data to draw firm conclusions.

FAMILIAL CANCER (2023)

Article Gastroenterology & Hepatology

Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines

Giulia Martina Cavestro, Alessandro Mannucci, Francesc Balaguer, Heather Hampel, Sonia S. Kupfer, Alessandro Repici, Andrea Sartore-Bianchi, Toni T. Seppala, Vincenzo Valentini, Clement Richard Boland, Randall E. Brand, Tineke E. Buffart, Carol A. Burke, Riccardo Caccialanza, Renato Cannizzaro, Stefano Cascinu, Andrea Cercek, Emma J. Crosbie, Silvio Danese, Evelien Dekker, Maria Daca-Alvarez, Francesco Deni, Mev Dominguez-Valentin, Cathy Eng, Ajay Goel, Jose G. Guillem, Britt B. S. L. Houwen, Charles Kahi, Matthew F. Kalady, Fay Kastrinos, Florian Kuehn, Luigi Laghi, Andrew Latchford, David Liska, Patrick Lynch, Alberto Malesci, Gianluca Mauri, Elisa Meldolesi, Pal Moller, Kevin J. Monahan, Gabriela Moeslein, Caitlin C. Murphy, Karlijn Nass, Kimmie Ng, Cristina Oliani, Enrico Papaleo, Swati G. Patel, Marta Puzzono, Andrea Remo, Luigi Ricciardiello, Carla Ida Ripamonti, Salvatore Siena, Satish K. Singh, Zsofia K. Stadler, Peter P. Stanich, Sapna Syngal, Stefano Turi, Emanuele Damiano Urso, Laura Valle, Valeria Stella Vanni, Eduardo Vilar, Marco Vitellaro, Yi-Qian Nancy You, Matthew B. Yurgelun, Raffaella Alessia Zuppardo, Elena M. Stoffel

Summary: This study aimed to develop guidelines for early-onset colorectal cancer (eoCRC). The study found that all individuals younger than 50 should undergo CRC risk stratification and newly diagnosed eoCRC patients should receive germline genetic testing. Furthermore, the treatment of early-onset CRC, including endoscopic, surgical, and oncologic treatment, should not differ from later-onset CRC, except for individuals with pathogenic or likely pathogenic germline variants. The study also highlighted areas for future research.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Review Oncology

A Focused Clinical Review of Lynch Syndrome

Demetra Georgiou, Laura Monje-Garcia, Tracie Miles, Kevin Monahan, Neil A. J. Ryan

Summary: Lynch syndrome is a hereditary condition that increases the risk of various cancers. Early detection is crucial for implementing cancer prevention strategies, but current interventions are invasive and not applicable to all associated cancers. New criteria, including universal screening, have led to an increased diagnosis of Lynch syndrome but also present challenges regarding consent and testing protocols.

CANCER MANAGEMENT AND RESEARCH (2023)

Review Oncology

Biology of Precancers and Opportunities for Cancer Interception: Lesson from Colorectal Cancer Susceptibility Syndromes

Kevin J. Monahan, Ottilie Swinyard, Andrew Latchford

Summary: Hereditary gastrointestinal cancer, specifically Lynch syndrome (LS) and familial adenomatous polyposis (FAP), has provided valuable insights into sporadic carcinogenesis and has facilitated the development of risk models and preventative strategies. The understanding of neoplasia-immune interaction in LS has led to the advancement of immune mediated therapies for cancer prevention, while chemoprevention with aspirin and nonsteroidal anti-inflammatory drugs has shown efficacy in LS but remains elusive in FAP. Additionally, controversies surrounding gastrointestinal surveillance in LS and FAP, including the limitations and opportunities of upper and lower gastrointestinal endoscopy, are discussed.

CANCER PREVENTION RESEARCH (2023)

Article Medicine, General & Internal

Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database

Mev Dominguez-Valentin, Saskia Haupt, Toni T. Seppaelae, Julian R. Sampson, Lone Sunde, Inge Bernstein, Mark A. Jenkins, Christoph Engel, Stefan Aretz, Maartje Nielsen, Gabriel Capella, Francesc Balaguer, Dafydd Gareth Evans, John Burn, Elke Holinski-Feder, Lucio Bertario, Bernardo Bonanni, Annika Lindblom, Zohar Levi, Finlay Macrae, Ingrid Winship, John-Paul Plazzer, Rolf Sijmons, Luigi Laghi, Adriana Della Valle, Karl Heinimann, Tadeusz Debniak, Robert Fruscio, Francisco Lopez-Koestner, Karin Alvarez-Valenzuela, Lor H. Katz, Ido Laish, Elez Vainer, Carlos Vaccaro, Dirce Maria Carraro, Kevin Monahan, Elizabeth Half, Aine Stakelum, Des Winter, Rory Kennelly, Nathan Gluck, Harsh Sheth, Naim Abu-Freha, Marc Greenblatt, Benedito Mauro Rossi, Mabel Bohorquez, Giulia Martina Cavestro, Leonardo S. Lino-Silva, Karoline Horisberger, Maria Grazia Tibiletti, Ivana do Nascimento, Huw Thomas, Norma Teresa Rossi, Leandro Apolinario da Silva, Attila Zarand, Juan Ruiz-Banobre, Vincent Heuveline, Jukka-Pekka Mecklin, Kirsi Pylvaenaeinen, Laura Renkonen-Sinisalo, Anna Lepistoe, Paeivi Peltomaeki, Christina Therkildsen, Mia Gebauer Madsen, Stefan Kobbelgaard Burgdorf, John L. Hopper, Aung Ko Win, Robert W. Haile, Noralane Lindor, Steven Gallinge, Loic Le Marchand, Polly A. Newcomb, Jane Figueiredo, Daniel D. Buchanan, Stephen N. Thibodeau, Magnus von Knebel Doeberitz, Markus Loeffler, Nils Rahner, Evelin Schroeck, Verena Steinke-Lange, Wolff Schmiegel, Deepak Vangala, Claudia Perne, Robert Hueneburg, Silke Redler, Reinhard Buettner, Jurgen Weitz, Marta Pineda, Nuria Duenas, Joan Brunet Vidal, Leticia Moreira, Ariadna Sanchez, Eivind Hovig, Sigve Nakken, Kate Green, Fiona Lalloo, James Hill, Emma Crosbie, Miriam Mints, Yael Goldberg, Douglas Tjandra, Sanne W. ten Broeke, Revital Kariv, Guy Rosner, Suresh H. Advani, Lidiya Thomas, Pankaj Shah, Mithun Shah, Florencia Neffa, Patricia Esperon, Walter Pavicic, Giovana Tardin Torrezan, Thiago Bassaneze, Claudia Alejandra Martin, Gabriela Moslein, Pal Moller

Summary: This study used the latest PLSD cohort to investigate the mortality rates and age of cancer diagnoses in carriers of pathogenic MMR variants. The results showed that non-colorectal Lynch syndrome cancers caused more deaths than colorectal cancers in these carriers. Reducing deaths from non-colorectal cancers is a crucial challenge for the medical care of Lynch syndrome.

ECLINICALMEDICINE (2023)

Article Gastroenterology & Hepatology

From diagnosis of colorectal cancer to diagnosis of Lynch syndrome: The RM Partners quality improvement project

Laura Monje-Garcia, Timothy Bill, Lindsay Farthing, Nate Hill, Emma Kipps, Angela F. F. Brady, Zoe Kemp, Katie Snape, Alistair Myers, Muti Abulafi, Kevin Monahan

Summary: This study aimed to measure geographic variation in Lynch syndrome (LS) testing among colorectal cancer (CRC) patients within the RM Partners West London cancer alliance and deliver an effective diagnostic pathway. The LS pathway audit revealed that improvement recommendations have been implemented, resulting in significant improvements in the percentage of patients undergoing tumor marker testing (p=0.008), further testing (p=0.03), and referral for genetic testing (p=0.02).

COLORECTAL DISEASE (2023)

Article Orthopedics

Return-to-Play Outcomes of Athletes After Operative and Nonoperative Treatment of Lumbar Disc Herniation

Shaelyn B. O'Connor, Kyle J. Holmberg, Jon E. Hammarstedt, Jonathan R. Acosta, Kevin Monahan, Ryan D. Sauber, Daniel T. Altman

Summary: The superiority of surgical or conservative treatment for athletes with lumbar disc herniation (LDH) is inconclusive. Surgical treatment may result in a quicker return to sport, but the outcomes vary based on the sport. Further research is needed to assist physicians and athletes in deciding between conservative or surgical treatment in the athletic population.

CURRENT REVIEWS IN MUSCULOSKELETAL MEDICINE (2023)

Review Oncology

Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statement

Pal Moller, Toni T. Seppala, Aysel Ahadova, Emma J. Crosbie, Elke Holinski-Feder, Rodney Scott, Saskia Haupt, Gabriela Moeslein, Ingrid Winship, Sanne W. Bajwa-ten Broeke, Kelly E. Kohut, Neil Ryan, Peter Bauerfeind, Laura E. Thomas, D. Gareth Evans, Stefan Aretz, Rolf H. Sijmons, Elizabeth Half, Karl Heinimann, Karoline Horisberger, Kevin Monahan, Christoph Engel, Giulia Martina Cavestro, Robert Fruscio, Naim Abu-Freha, Levi Zohar, Luigi Laghi, Lucio Bertario, Bernardo Bonanni, Maria Grazia Tibiletti, Leonardo S. Lino-Silva, Carlos Vaccaro, Adriana Della Valle, Benedito Mauro Rossi, Leandro Apolinario da Silva, Ivana Lucia de Oliveira Nascimento, Norma Teresa Rossi, Tadeusz Debniak, Jukka-Pekka Mecklin, Inge Bernstein, Annika Lindblom, Lone Sunde, Sigve Nakken, Vincent Heuveline, John Burn, Eivind Hovig, Matthias Kloor, Julian R. Sampson, Mev Dominguez-Valentin, Prospective Lynch Syndrome Database, European Hereditary Tumour Grp

Summary: The recognition of hereditary micro-satellite instable (MSI) cancers caused by pathogenic variants in mismatch repair (MMR) genes has changed our understanding of carcinogenesis. The four Lynch syndromes, each caused by loss of function variants in MMR genes, are characterized by different levels and types of cancer. In Lynch syndromes, carcinogenesis follows a linear process with a dynamic balance between MSI production and the host's immune system. Colonoscopy surveillance, aspirin prevention, and immunotherapy are important advancements in preventing and treating hereditary MSI cancer.

HEREDITARY CANCER IN CLINICAL PRACTICE (2023)

Meeting Abstract Gastroenterology & Hepatology

Finding the missing 95%: the English national lynch syndrome transformation project

Kevin Monahan, Adam C. Shaw, Laura Laura Monje-Garcia, Francesca Faravelli, Simone Gelinas, Frances Elmslie, Adele Tyson, Steven Hardy

Meeting Abstract Gastroenterology & Hepatology

Psychological well-being of people living with a colorectal cancer predisposition syndrome: evidence from a systematic review

Laura Monje-Garcia, Jai Vairale, Hilary Watt, Sondus Hassounah, Heidi Lai, Kevin Monahan

Meeting Abstract Gastroenterology & Hepatology

Co-evolution of mismatch repair loss and the immune response in Lynch Syndrome

Ottilie Swinyard, Ann-Marie Baker, Kevin Monahan, Marnix Jansen, Calum Gabbutt, Chris Kimberley, Trevor Graham, Jacob Househam, Eszter Lakatos

Meeting Abstract Gastroenterology & Hepatology

The diagnostic yield of colonoscopic surveillance following resection of early-age onset colorectal cancer (EOCRC)

Husam Al Maliki, Kevin J. Monahan

Meeting Abstract Gastroenterology & Hepatology

Endoscopic scar excision for previous R1 resection of advanced neoplasia in the rectum

Robert Eckersley, Kevin Monahan, Noriko Suzuki

Meeting Abstract Gastroenterology & Hepatology

DELPHI INITIATIVE FOR EARLY-ONSET COLORECTAL CANCER (DIRECT): INTERNATIONAL MANAGEMENT GUIDELINES

G. M. Cavestro, A. Mannucci, F. Balaguer, H. Heather, S. Kupfer, A. Repici, A. Sartore-Bianchi, T. T. Seppala, V. Valentini, C. R. Boland, R. E. Brand, T. Buffart, C. A. Burke, R. Caccialanza, R. Cannizzaro, S. Cascinu, A. Cercek, E. J. Crosbie, S. Danese, E. Dekker, M. Daca-Alvarez, F. Deni, A. Latchford, D. Liska, P. Lynch, A. Malesci, G. Mauri, E. Meldolesi, M. Pal, K. J. Monahan, G. Moslein, C. C. Murphy, K. Nass, K. Ng, C. Oliani, E. Papaleo, S. Patel, M. Puzzono, A. Remo, L. Ricciardiello, C. I. Ripamonti, S. Siena, S. K. Singh, Z. Stadler, P. P. Stanich, S. Syngal, S. Turi, E. D. Urso, L. Valle, V. S. Vanni, E. Vilar, M. Vitellaro, Y. N. You, M. B. Yurgelun, R. A. Zuppardo, E. M. Stoffel

DIGESTIVE AND LIVER DISEASE (2023)

No Data Available